logo

Moehs collects the Business Initiative Award of the 2019 Demarcation

Moehs collects the Business Initiative Award of the 2019 Demarcation

Leave a Comment / By

On July 11, the Cambra 2019 awards ceremony was held, granted by the Cambra de Terrassa.

The award ceremony was held on July 11, 2019, at the Cultural Center of Terrassa, and was attended by more than 500 people, business executives and professional, political and economic and institutional representatives of Catalonia. The President of the Generalitat, Quim Torra, attended the ceremony.

Within an exciting night, Moehs picked up the Business Initiative Award, one of the most important awards in the competition and recognized by the entire professional sector.

At this time again we would like to thank the efforts of the entire company to be every day an example of quality, work and honesty. In addition, from our deepest pride, we also want to thank all those people who are part of the group, their dedication and their daily professional work, which makes it possible to achieve recognitions like this, to maintain our path to the future.

Click to see the photos:

Leave a Comment

Your email address will not be published. Required fields are marked *

logo
Twitter Linkedin-in
  • Headquarters:
  • Pol. Ind. Cova Solera
  • c/Roma, 8-12 08191 Rubí.
  • Barcelona (Spain)
  • T +34 93 586 05 20
  • Fax +34 93 588 85 13
  • info@moehs.es

Partnering companies

The Board of Directors of the Center for Technological Development and Innovation, E.P.E (CDTI), in its meeting held on 02/23/2023, approved the participation of this center in the research and development project called SYNTHESIS OF A STIMULATOR ACTIVE PRINCIPLE OF SOLUBLE CYCLASE GUANYLATE by granting partially reimbursable aid.

The objective is focused on the development of a new method of chemical synthesis of an active ingredient that stimulates soluble guanylate cyclase.

The project will be carried out at the Rubí facilities. The project execution period is from 2022 to 2024 and they have a financeable budget of €1,862,213.00.
This project is co-financed by the European Union and CDTI.

The Board of Directors of the Center for Technological Development and Innovation, E.P.E (CDTI), in its meeting held on 02/23/2023, approved the participation of this center in the research and development project called SYNTHESIS OF AN ACTIVE INHIBITOR PRINCIPLE OF JANUS KINASE FOR THE TREATMENT OF ATOPIC DERMATITIS.”, by granting partially reimbursable aid.

The objective is focused on the development of a new method of chemical synthesis of a janus kinase inhibitor active ingredient for the treatment of atopic dermatitis.

The project will be carried out at the Rubí facilities. The project execution period is from 2022 to 2025 and they have a financeable budget of €1,940,409.
This project is co-financed by the European Union and CDTI.